Pfizer, Moderna, Regeneron and many other healthcare companies presented at the 40th annual J.P. Morgan Healthcare Conference and outlined their plans to continue fighting Covid this year.
Dr. Matt Binnicker, an expert in the diagnosis of infectious diseases, reviews scenarios where an at-home antigen test is a good option, and when to seek out a lab-based PCR.
Dr. Anand Parekh, chief medical advisor for the Bipartisan Policy Center, discusses how the U.S. can bolster its response to the spread of the omicron variant.
In a key decision, the Centers for Medicare and Medicaid Services (CMS) said today that Medicare will not pay for the controversial Alzheimer’s drug Adulhelm until it sees positive results from a government-approved trial.
The San Francisco-based startup uses AI to transcribe doctors’ interactions with their patients, which saves them an average of three hours of work a day.